Show Summary Details
Page of

Pulmonary Hypertension 

Pulmonary Hypertension
Pulmonary Hypertension

Renata G. Ferreira

, and Andreas Schuler

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 04 August 2020

Pulmonary hypertension (PHTN) is a rare yet devastating disease. PHTN is defined as a mean pulmonary artery pressure of 25 mm Hg or greater at rest, measured during right heart catheterization. The survival without therapy is only 2.8 years. Its estimated prevalence ranges from 0.001 to 0.01. In noncardiac surgery, PHTN is considered to be an important predictor of complications, with perioperative morbidity ranging from 14% to 24%. Given this potential morbidity, careful preoperative evaluation and understanding of risks and management of these patients is strongly encouraged as it may improve outcomes after surgery. The perioperative risk and management among patients with PHTN undergoing noncardiac surgery may differ. Therefore, it is important for the anesthesiologist to understand the underlying disease process causing elevation of the pulmonary artery pressure when evaluating the risks and benefits of the proposed procedure.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.